Screener
Dyne Therapeutics, Inc. DYN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 214,895 | 214,829 |
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 165,201,329 and 164,950,540 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 16 | 16 |
| Additional paid-in capital | 2,382,172 | 2,367,780 |
| Accumulated other comprehensive loss (gain) | (137) | 475 |
| Accumulated deficit | (1,516,996) | (1,396,142) |
| Total stockholders’ equity | 865,055 | 972,129 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s common stock?
- Dyne Therapeutics, Inc. (DYN) reported common stock of $16K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s common stock changed year-over-year?
- Dyne Therapeutics, Inc.'s common stock increased by 45.5% year-over-year, from $11K to $16K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s common stock has grown at a 26.2% compound annual growth rate (CAGR), from $5K to $16K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Dyne Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude